Conference abstract · 2 Nov 2015
Conference abstractPublished 15 Aug 2016
MicroRNA: A small non-coding RNA, an efficient biomarker for prostate cancer
Loyola College, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Prostate cancer is the second leading cancer for men in America and Europe. Prostate cancer development is a slow process in men commonly over the age of fifty years. There are still poor in tools or biomarkers to identify in its early stage of development. Currently clinicians are using prostate specific antigen testing (PSA) and digital rectal examination (DRE) as early diagnostic tools for identifying prostate cancer but it shows ineffective due to low specificity and poor sensitivity. Therefore a novel biomarker for diagnosis of prostate cancer is required. A large quantity of microRNAs (miRNAs) is built up of 18-23 nucleotide; they are small non-coding and single-stranded and are important in post-transcriptional regulation of gene expression by degrading or suppressing target gene mRNAs. MiRNAs are implicated in the pathogenesis of prostate cancer; however they also act as novel target for the therapeutic intervention and circular microRNAs are shown potential biomarker for the prostate cancer diagnosis and show more specificity and sensitivity compared to available tools/biomarkers.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 6 Aug 2018
Non-coding RNA involvement in cancer: The case for Neuroblastoma
Conference abstract · 19 May 2016
The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis
Commentary · 29 Jan 2025
Advancing drug discovery: The role of non-coding rna therapeutics and organoid models for drug screening
Conference abstract · 23 Sep 2022
Discovery of long non-coding rna biomarkers for breast cancer Subtypes using machine learning
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectNephrology & Urology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Khanmi kasomva”
